Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Shares Issued (2016 - 2025)

Abeona Therapeutics (ABEO) has 12 years of Shares Issued data on record, last reported at $10.5 million in Q2 2025.

  • For Q2 2025, Shares Issued fell 83.52% year-over-year to $10.5 million; the TTM value through Jun 2025 reached -$37.4 million, down 147.96%, while the annual FY2024 figure was $15.5 million, 7.41% up from the prior year.
  • Shares Issued reached $10.5 million in Q2 2025 per ABEO's latest filing, up from $6.8 million in the prior quarter.
  • Across five years, Shares Issued topped out at $63.7 million in Q2 2024 and bottomed at -$54.7 million in Q4 2024.
  • Average Shares Issued over 5 years is $7.0 million, with a median of $6.4 million recorded in 2024.
  • Peak YoY movement for Shares Issued: soared 17500.0% in 2021, then crashed 802.35% in 2024.
  • A 5-year view of Shares Issued shows it stood at $352000.0 in 2021, then skyrocketed by 7971.31% to $28.4 million in 2022, then crashed by 72.6% to $7.8 million in 2023, then plummeted by 802.35% to -$54.7 million in 2024, then skyrocketed by 119.21% to $10.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $10.5 million in Q2 2025, $6.8 million in Q1 2025, and -$54.7 million in Q4 2024.